Case File №
#VI-2026-0524
Alimo Peptide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
44 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | D Poor | 4 | 6.4 | 3.8 | 10.0 | 11 Jun 2025 |
| Retatrutide | E Bad | 3 | 2.9 | 0.0 | 4.4 | 11 Jun 2025 |
| ACE-031 | X N/A | 1 | 4.0 | 1.5 | 1.5 | 20 Jun 2025 |
| Anavar (Oxandrolone) Raw | X N/A | 1 | 5.2 | 5.2 | 5.2 | 20 Jun 2025 |
| Aromasin (Exemestane) | X N/A | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 |
| BAM15 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 4.2 | 4.2 | 4.2 | 6 May 2025 |
| Boldenone Cypionate | X N/A | 1 | 4.6 | 4.6 | 4.6 | 17 Dec 2024 |
| Boldenone Undecylenate (EQ) Raw | X N/A | 1 | 4.2 | 4.2 | 4.2 | 13 Jun 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 7.8 | 7.8 | 7.8 | 17 Dec 2024 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.6 | 4.6 | 4.6 | 8 Jul 2025 |
| CJC-1295 With DAC | X N/A | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 4.0 | 1.8 | 1.8 | 3 Jun 2025 |
| Clenbuterol | X N/A | 1 | 4.0 | 4.0 | 4.0 | 16 Mar 2025 |
| DNP | X N/A | 1 | 4.0 | 3.4 | 3.4 | 7 May 2025 |
| EPO | X N/A | 1 | 4.8 | 4.8 | 4.8 | 21 May 2025 |
| GHRP-6 Acetate | X N/A | 1 | 4.0 | 2.9 | 2.9 | 14 Jan 2025 |
| HCG | X N/A | 1 | 4.0 | 4.0 | 4.0 | 21 May 2025 |
| Hexarelin | X N/A | 1 | 4.0 | 3.6 | 3.6 | 28 Mar 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 6.3 | 6.3 | 6.3 | 3 Jun 2025 |
| Liraglutide | X N/A | 1 | 5.1 | 5.1 | 5.1 | 11 Jun 2025 |
| Minoxidil Oral | X N/A | 1 | 5.0 | 5.0 | 5.0 | 25 Apr 2025 |
| MOTS-C | X N/A | 1 | 4.7 | 4.7 | 4.7 | 6 May 2025 |
| MT-1 | X N/A | 1 | 4.0 | 3.5 | 3.5 | 16 Mar 2025 |
| NAD+ | X N/A | 1 | 4.8 | 4.8 | 4.8 | 16 Mar 2025 |
| NandroMix 300 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 |
| NPP | X N/A | 1 | 4.0 | 2.7 | 2.7 | 28 Mar 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 4.1 | 4.1 | 4.1 | 24 Apr 2025 |
| Ovagen | X N/A | 1 | 6.1 | 6.1 | 6.1 | 25 Apr 2025 |
| P21 | X N/A | 1 | 4.0 | 3.9 | 3.9 | 16 Mar 2025 |
| PE 22-28 | X N/A | 1 | 5.1 | 5.1 | 5.1 | 2 Jul 2025 |
| Prednisone | X N/A | 1 | 5.3 | 5.3 | 5.3 | 28 Mar 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 3.8 | 3.8 | 9 Jun 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 6.1 | 6.1 | 6.1 | 25 Apr 2025 |
| Sildenafil (Viagra) | X N/A | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
| SR9009 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 7 May 2025 |
| SS-31 (Elamipretide) Raw | X N/A | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 |
| TB-500 FRAG | X N/A | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| Testagen | X N/A | 1 | 4.0 | 2.6 | 2.6 | 14 Jan 2025 |
| Tren Hex | X N/A | 1 | 4.0 | 3.9 | 3.9 | 24 Apr 2025 |
| Trenbolone Acetate Raw | X N/A | 1 | 4.0 | 3.9 | 3.9 | 14 Jan 2025 |
| Vesugen | X N/A | 1 | 6.2 | 6.2 | 6.2 | 6 May 2025 |
| Vilon | X N/A | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 4.1 | 4.1 | 4.1 | 11 Jun 2025 |
Exhibit II
Evidence Log
49 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | NAD+ | 4.0 C | 5mg | 4.4mg | -11.7% | 96.23% | bxczvg | Lab A | Public |
| 25 May 2026 | NPP | 4.0 C | 300mg/ml | 354.7mg/ml | +18.2% | 99.26% | tmvs4q | Lab B | Public |
| 24 May 2026 | Anavar (Oxandrolone) Raw | 5.9 B | 500g | 533.9g | +6.8% | 99.52% | wx22yj | Lab A | Community |
| 24 May 2026 | Aromasin (Exemestane) | 5.8 B | 100mg | 93.0mg | -7.0% | 97.32% | lplvn2 | Lab B | Public |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.0 C | 15mg | 17.8mg | +18.4% | 98.15% | rl5lkp | Lab G | Public |
| 24 May 2026 | MT-1 | 6.7 A | 30mg | 33.7mg | +12.3% | 98.49% | xoxg2d | Lab B | Community |
| 24 May 2026 | Ovagen | 4.7 C | 20mg | 22.5mg | +12.5% | 95.24% | 57eij1 | Lab F | Public |
| 24 May 2026 | Vilon | 5.2 B | 10mg | 12.4mg | +24.1% | 98.26% | ph1g3e | Lab A | Community |
| 24 May 2026 | Boldenone Cypionate | 5.5 B | 250mg/ml | 219.3mg/ml | -12.3% | 99.25% | ao4ooj | Lab G | Public |
| 24 May 2026 | Ostarine (MK-2866) | 4.3 C | 25mg | 31.2mg | +24.7% | 97.11% | 5x6xk3 | Lab D | Public |
| 24 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.4 A | 5mg | 5.3mg | +6.4% | 95.69% | 5smuzm | Lab C | Community |
| 24 May 2026 | P21 | 5.1 B | 10mg | 8.7mg | -12.7% | 95.29% | dxz5nn | Lab A | Community |
| 23 May 2026 | Liraglutide | 4.3 C | 20mg | 25.0mg | +24.9% | 96.45% | 7nmc7m | Lab F | Community |
| 23 May 2026 | SR9009 | 6.1 A | 100mg | 100.0mg | +0.0% | 95.48% | yl1luo | Lab B | Public |
| 23 May 2026 | Trenbolone Acetate Raw | 4.0 C | 10g | 12.0g | +20.2% | 97.59% | bce6n4 | Lab C | Community |
| 23 May 2026 | Vesugen | 7.3 A | 20mg | 21.8mg | +9.2% | 97.53% | v9ik54 | Lab B | Public |
| 21 May 2026 | Blend 300 (TRA/Mast P/Test P) | 6.1 A | 100mg/ml | 109.2mg/ml | +9.2% | 98.67% | kqxz81 | Lab A | Community |
| 21 May 2026 | Hexarelin | 4.0 C | 5mg | 6.1mg | +22.5% | 95.37% | e68648 | Lab B | Public |
| 21 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.0 C | 50mg | 59.8mg | +19.6% | 95.14% | 4dy0qu | Lab G | Public |
| 21 May 2026 | HCG | 4.0 C | 10mg | 9.6mg | -4.3% | 98.65% | ximobe | Lab C | Community |
| 21 May 2026 | MOTS-C | 4.0 C | 15mg | 17.1mg | +14.3% | 97.31% | zuipje | Lab B | Public |
| 21 May 2026 | Tren Hex | 5.4 B | 300mg/ml | 293.7mg/ml | -2.1% | 99.31% | mqpmp2 | Lab B | Community |
| 21 May 2026 | Vitamin B12 1mg/ml | 4.0 C | 300mg/ml | 324.1mg/ml | +8.0% | 98.53% | wej28o | Lab A | Community |
| 17 May 2026 | NandroMix 300 | 4.8 C | 250mg/ml | 275.8mg/ml | +10.3% | 96.87% | kmt0p2 | Lab C | Public |
| 29 Jan 2026 | SS-31 (Elamipretide) Raw | 4.8 C | 1g | 1.0g | -3.7% | 97.82% | w8cl1v | Lab B | Public |
| 7 Jan 2026 | GHRP-6 Acetate | 6.8 A | 30mg | 27.7mg | -7.8% | 96.38% | 1og75c | Lab F | Community |
| 6 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 7.4 A | 2mg | 2.0mg | -0.2% | 95.26% | 3dpbqi | Lab B | Public |
| 6 Jan 2026 | Retatrutide 30mg Pen Kit | 8.4 A | 20mg | 18.7mg | -6.5% | 96.62% | pd5vvn | Lab C | Public |
| 29 Dec 2025 | BAM15 | 7.6 A | 25mg | 25.8mg | +3.1% | 99.74% | j9p1xy | Lab B | Community |
| 29 Dec 2025 | DNP | 6.2 A | 10mg | 12.0mg | +19.8% | 96.11% | xk0r38 | Lab C | Community |
| 29 Dec 2025 | EPO | 6.1 A | 15mg | 13.6mg | -9.3% | 96.78% | 4cdpj3 | Lab A | Public |
| 29 Dec 2025 | TB-500 FRAG | 5.7 B | 20mg | 24.8mg | +24.1% | 97.31% | 3hb5bd | Lab C | Community |
| 29 Dec 2025 | Testagen | 4.8 C | 50mg | 61.3mg | +22.6% | 96.29% | zekgiv | Lab E | Public |
| 12 Dec 2025 | ACE-031 | 5.8 B | 5mg | 5.0mg | +0.7% | 96.10% | qr7fga | Lab G | Community |
| 12 Dec 2025 | Prednisone | 7.1 A | 25mg | 25.9mg | +3.4% | 95.56% | qp1i6y | Lab D | Public |
| 5 Dec 2025 | Clenbuterol | 4.0 C | 50mg | 57.6mg | +15.1% | 99.73% | ieo2tf | Lab D | Public |
| 5 Dec 2025 | PE 22-28 | 7.7 A | 30mg | 29.3mg | -2.3% | 98.47% | vbnoki | Lab G | Public |
| 5 Dec 2025 | PTD-DBM | 4.0 C | 50mg | 57.1mg | +14.2% | 97.07% | ymaeok | Lab A | Community |
| 23 Nov 2025 | Sildenafil (Viagra) | 7.4 A | 50mg | 46.9mg | -6.2% | 97.37% | zz9e8t | Lab F | Community |
| 4 Nov 2025 | Minoxidil Oral | 4.0 C | 25mg | 26.1mg | +4.3% | 95.06% | tr4si8 | Lab C | Public |
| 17 Oct 2025 | CJC-1295 With DAC | 4.7 C | 20mg | 18.0mg | -9.9% | 95.85% | 7ilrz9 | Lab F | Public |
| 13 Oct 2025 | Retatrutide | 4.4 D | 20mg | (no batch claim) | 23.7mg | +18.5% | 99.60% | No Label / Silver Crimp / Green Cap | Lab G |
| 3 Oct 2025 | Boldenone Undecylenate (EQ) Raw | 4.0 C | 5g | 4.5g | -10.9% | 98.87% | w2ua3v | Lab G | Public |
| 11 Aug 2025 | Tirzepatide | 10.0 A | 60mg | 64.2mglabel | 62mg | -3.4% | 99.94% | No Label / Copper Crimp / Clear Cap | Lab E |
| 5 Aug 2025 | Tirzepatide | 4.0 D | 60mg | (no batch claim) | 90mg | +50.0% | 99.64% | No Label / Copper Crimp / Clear Cap | Lab E |
| 4 Aug 2025 | Retatrutide | 0.0 E | 15mg | ⚠️ Sample does not contain Retatrutide ? | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | — | — |
| 29 Jun 2025 | Tirzepatide | 3.8 E | 30mg | (no batch claim) | 53.6mg | +78.7% | 99.71% | No Label / Silver Crimp / Red Cap | Lab E |
| 11 Jun 2025 | Tirzepatide | 7.8 A | 40mg | (no batch claim) | 39.5mg | -1.3% | 99.80% | No Label / Silver Crimp / Green Cap | Lab E |
| 11 Jun 2025 | Retatrutide | 4.1 D | 20mg | (no batch claim) | 33.8mg | +69.0% | 99.79% | No Label / Silver Crimp / Yellow Cap | Lab E |
— END OF EVIDENCE LOG —